Meissner, J., Fliegauf, M., Grimbacher, B., & Klemann, C. (ca. 2024). Type-specific impacts of protein defects in pathogenic NFKB2 variants: novel clinical findings from 138 patients [Cd]. Universität. https://doi.org/10.1016/j.jaip.2024.10.015
The Open University - HarvardMeissner, J., Fliegauf, M., Grimbacher, B. und Klemann, C. (2024) Type-specific impacts of protein defects in pathogenic NFKB2 variants: novel clinical findings from 138 patients, Freiburg, Universität [Online]. DOI: 10.1016/j.jaip.2024.10.015.
IEEE[1]J. Meissner, M. Fliegauf, B. Grimbacher, und C. Klemann, Type-specific impacts of protein defects in pathogenic NFKB2 variants: novel clinical findings from 138 patients. Freiburg: Universität, 2024. doi: 10.1016/j.jaip.2024.10.015.
Vancouver1. Meissner J, Fliegauf M, Grimbacher B, Klemann C. Type-specific impacts of protein defects in pathogenic NFKB2 variants: novel clinical findings from 138 patients. Freiburg: Universität; 2024. 1 Online-Ressource.
Betriebswirtschaftliche Forschung und Praxis (Deutsch)Meissner, J./Fliegauf, M./Grimbacher, B./Klemann, C. (2024), Type-specific impacts of protein defects in pathogenic NFKB2 variants: novel clinical findings from 138 patients, Freiburg.